Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines.

Peng S, Monie A, Pang X, Hung CF, Wu TC.

J Biomed Sci. 2011 Mar 8;18:21. doi: 10.1186/1423-0127-18-21.

PMID:
21385449
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents.

Zeng Q, Peng S, Monie A, Yang M, Pang X, Hung CF, Wu TC.

Hum Gene Ther. 2011 Jul;22(7):809-19. doi: 10.1089/hum.2010.071. Epub 2011 Mar 9.

PMID:
21128743
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination.

Chuang CM, Monie A, Hung CF, Wu TC.

J Biomed Sci. 2010 Apr 28;17:32. doi: 10.1186/1423-0127-17-32.

PMID:
20426849
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.

Lee SY, Huang Z, Kang TH, Soong RS, Knoff J, Axenfeld E, Wang C, Alvarez RD, Chen CS, Hung CF, Wu TC.

J Mol Med (Berl). 2013 Oct;91(10):1221-31. doi: 10.1007/s00109-013-1054-9. Epub 2013 May 29.

PMID:
23715898
[PubMed - indexed for MEDLINE]
5.

Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination.

Tseng CW, Hung CF, Alvarez RD, Trimble C, Huh WK, Kim D, Chuang CM, Lin CT, Tsai YC, He L, Monie A, Wu TC.

Clin Cancer Res. 2008 May 15;14(10):3185-92. doi: 10.1158/1078-0432.CCR-08-0037.

PMID:
18483387
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts.

Tseng CW, Trimble C, Zeng Q, Monie A, Alvarez RD, Huh WK, Hoory T, Wang MC, Hung CF, Wu TC.

Cancer Immunol Immunother. 2009 May;58(5):737-48. doi: 10.1007/s00262-008-0596-0. Epub 2008 Sep 25.

PMID:
18815785
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects.

Lee SY, Kang TH, Knoff J, Huang Z, Soong RS, Alvarez RD, Hung CF, Wu TC.

Cancer Immunol Immunother. 2013 Jul;62(7):1175-85. doi: 10.1007/s00262-013-1421-y. Epub 2013 Apr 25.

PMID:
23615841
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D.

Diniz MO, Lasaro MO, Ertl HC, Ferreira LC.

Clin Vaccine Immunol. 2010 Oct;17(10):1576-83. doi: 10.1128/CVI.00264-10. Epub 2010 Aug 25.

PMID:
20739505
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.

Peng S, Trimble C, He L, Tsai YC, Lin CT, Boyd DA, Pardoll D, Hung CF, Wu TC.

Gene Ther. 2006 Jan;13(1):67-77.

PMID:
16107858
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects.

Tseng CW, Monie A, Trimble C, Alvarez RD, Huh WK, Buchsbaum DJ, Straughn JM Jr, Wang MC, Yagita H, Hung CF, Wu TC.

Vaccine. 2008 Aug 12;26(34):4314-9. doi: 10.1016/j.vaccine.2008.06.049. Epub 2008 Jul 1.

PMID:
18598733
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination.

Tseng CW, Monie A, Wu CY, Huang B, Wang MC, Hung CF, Wu TC.

J Mol Med (Berl). 2008 Aug;86(8):899-908. doi: 10.1007/s00109-008-0370-y. Epub 2008 Jun 10.

PMID:
18542898
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects.

Peng S, Trimble C, Alvarez RD, Huh WK, Lin Z, Monie A, Hung CF, Wu TC.

Gene Ther. 2008 Aug;15(16):1156-66. doi: 10.1038/gt.2008.53. Epub 2008 Apr 10.

PMID:
18401437
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.

Lin CT, Tsai YC, He L, Yeh CN, Chang TC, Soong YK, Monie A, Hung CF, Lai CH.

Immunol Lett. 2007 Dec 15;114(2):86-93. Epub 2007 Oct 16.

PMID:
17976741
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine.

Peng S, Lyford-Pike S, Akpeng B, Wu A, Hung CF, Hannaman D, Saunders JR, Wu TC, Pai SI.

Cancer Immunol Immunother. 2013 Jan;62(1):171-82. doi: 10.1007/s00262-012-1322-5. Epub 2012 Aug 4.

PMID:
23011589
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.

Seo SH, Jin HT, Park SH, Youn JI, Sung YC.

Vaccine. 2009 Sep 25;27(42):5906-12. doi: 10.1016/j.vaccine.2009.07.033. Epub 2009 Aug 3.

PMID:
19651174
[PubMed - indexed for MEDLINE]
16.

Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.

Jassar AS, Suzuki E, Kapoor V, Sun J, Silverberg MB, Cheung L, Burdick MD, Strieter RM, Ching LM, Kaiser LR, Albelda SM.

Cancer Res. 2005 Dec 15;65(24):11752-61.

PMID:
16357188
[PubMed - indexed for MEDLINE]
Free Article
17.

Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control.

Lee IH, Park JB, Cheong M, Choi YS, Park D, Sin JI.

DNA Cell Biol. 2011 Dec;30(12):975-85. doi: 10.1089/dna.2011.1266. Epub 2011 Jun 7.

PMID:
21649506
[PubMed - indexed for MEDLINE]
18.

[Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].

Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2007 Oct;29(5):584-91. Chinese.

PMID:
18051710
[PubMed - indexed for MEDLINE]
Free Article
19.

Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.

Kang TH, Chung JY, Monie A, Pai SI, Hung CF, Wu TC.

Gene Ther. 2010 Apr;17(4):531-40. doi: 10.1038/gt.2009.152. Epub 2009 Nov 26.

PMID:
19940864
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors.

Ji H, Wang TL, Chen CH, Pai SI, Hung CF, Lin KY, Kurman RJ, Pardoll DM, Wu TC.

Hum Gene Ther. 1999 Nov 20;10(17):2727-40.

PMID:
10584920
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk